choi dennis (29 Ergebnisse)

Hardcover. Zustand: As New. No Jacket. Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less.

Zustand: Very Good. Very Good condition. A copy that may have a few cosmetic defects. May also contain light spine creasing or a few markings such as an owner's name, short gifter's inscription or light stamp.

Zustand: Good. 4th Edition. Ships from the UK. Former library book; may include library markings. Used book that is in clean, average condition without any missing pages.

8°, hardcover. Zustand: Gut. first Edition. 455 S. Dustjacket, good condition Sprache: Englisch Gewicht in Gramm: 1100.

Zustand: Good. Volume 155. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. Clean from markings In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,950grams, ISBN:9783540424123.

Zustand: Good. 2002nd Edition. Former library book; may include library markings. Used book that is in clean, average condition without any missing pages.

Paperback. Zustand: Brand New. 240 pages. 9.00x6.00x0.63 inches. In Stock.

Paperback. Zustand: Brand New. 158 pages. 9.00x6.00x0.40 inches. In Stock.

Hardcover. Zustand: Brand New. 240 pages. 9.00x6.00x0.88 inches. In Stock.

Hardcover/Pappeinband. Zustand: Gut. XII, 155 S. : graph. Darst. ; 25 cm Minimal bestossen, innen sehr gut. F3 Sprache: Englisch Gewicht in Gramm: 550.

Hardcover. Zustand: Brand New. 400 pages. 11.00x1.19x8.50 inches. In Stock.

Hardcover. Zustand: Brand New. 147 pages. 9.00x6.00x0.75 inches. In Stock.

Paperback. Zustand: Brand New. reprint edition. 167 pages. 9.50x6.00x0.50 inches. In Stock.

Hardcover. Zustand: Brand New. 242 pages. 9.00x6.00x9.00 inches. In Stock.

Taschenbuch. Zustand: Neu. Glutamate, Cell Death and Memory | Philippe Ascher (u. a.) | Taschenbuch | xii | Englisch | 2011 | Springer | EAN 9783642845284 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - In the past few years, the Fondation IPSEN has been increasing its activity in the neurosciences, especially by supporting researchers working on Alzheimer's disease. This interest in the subject is demonstrated by a prize and a fellowship, which have been awarded each year since 1985, a monthly newsletter, and a series of Colloques Medecine et Recherche and their proceedings which are distributed world-wide. Since 1990, our effort in the field of neuroscience has been considerably enhanced. A new series of Colloques Medecine et Recherche has been devoted to this topic. Like the meetings on Alzheimer's disease, this series will deal with the most current research. Glutamate -the subject we chose for the first meeting of this series - is an excellent example since it has a major role in many physiological or pathological situations. This book contains the proceedings of the meeting which was held in Paris on September 24, 1990. As for the proceedings of the meeting on Alzheimer's disease - published in the series Research and Perspectives in Alzheimer's disease -these meetings will be reported in a new series, distributed at an international level, Research and Perspectives in Neurosciences. The second meeting on neurosciences is scheduled for September 23, 1991, and will be held in Paris. It will be dedicated to Gene transfer and therapy in the nervous system (Organizing Committee: F. Gage, La Jolla; Y. Christen, Paris).

Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher.

Gebunden. Zustand: New. In this book, an international group of investigators from a broad array of clinical and basic disciplines present the ideas and concepts in the foreground of cerebrovascular disease. Included in their discussion are perspectives on topics that continue to .

Hardcover. Zustand: Brand New. 1st edition. 455 pages. 9.35x6.50x1.25 inches. In Stock.

Zustand: New. In this book, an international group of investigators from a broad array of clinical and basic disciplines present the ideas and concepts in the foreground of cerebrovascular disease. Included in their discussion are perspectives on topics that continue to guide current investigations. Editor(s): Choi, Dennis W.; Dacey, Ralph G.; Hsu, Chung Y.; Powers, William. Series: American Heart Association Monograph S. Num Pages: 455 pages, 84 illustrations. BIC Classification: MJC; MJD. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 163 x 35. Weight in Grams: 956. . 2001. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.

Buch. Zustand: Neu. Neuware - In this book, an international group of investigators from a broad array of clinical and basic disciplines present the ideas and concepts in the foreground of cerebrovascular disease.

Taschenbuch. Zustand: Neu. CNS Neuroprotection | Dennis W. Choi (u. a.) | Taschenbuch | xxii | Englisch | 2010 | Springer Berlin | EAN 9783642076251 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Buch. Zustand: Neu. Neuware -'CNS neuroprotection' was a common subject of papers, symposia, and reviews during the previous 'decade of the brain. ' Indeed, in recent years, experimental study of putative neuroprotective agents prompted clinical trials of numerous drug candidates in acute and chronic human neurodegenerative conditions. While the outcomes of these trials have not been as successful as initially hoped, these were early explorations, and the pipeline of relevant ideas continues to grow in strength and depth. We predict that early in this new millennium, crippling disorders such as stroke and Alzheimer's disease will be treated effectively by therapeutic neuroprotective strategies. This volume of the Handbook of Experimental Pharmacology titled eNS Neuroprotection provides a pharmacological perspective on currently promis ing neuroprotective approaches, and a clinical perspective on the challenges involved in establishing the efficacy of these approaches through appropriate clinical trials. Section I, 'Mechanistic Approaches to CNS Neuroprotection,' reviews major injury mechanisms that have formed the basis for many past and present clinical trials conducted around the world. Dr. KIM and colleagues, Washington University School of Medicine, review the status of blocking excitotoxicity as an approach to CNS neuroprotection. Dr. WANG, Pfizer Global Research and Development,Ann Arbor Laboratories, outlines evidence supporting a contri bution of apoptosis to pathological neuronal or glial cell loss. Drs. BECKER and HALLENBECK, University of Washington and the National Institute on Neuro logical Diseases and Stroke, respectively, argue that inhibiting inflammatory pathways in the brain can be neuroprotective. Dr. 524 pp. Englisch.

Taschenbuch. Zustand: Neu. Neuware -'CNS neuroprotection' was a common subject of papers, symposia, and reviews during the previous 'decade of the brain. ' Indeed, in recent years, experimental study of putative neuroprotective agents prompted clinical trials of numerous drug candidates in acute and chronic human neurodegenerative conditions. While the outcomes of these trials have not been as successful as initially hoped, these were early explorations, and the pipeline of relevant ideas continues to grow in strength and depth. We predict that early in this new millennium, crippling disorders such as stroke and Alzheimer's disease will be treated effectively by therapeutic neuroprotective strategies. This volume of the Handbook of Experimental Pharmacology titled eNS Neuroprotection provides a pharmacological perspective on currently promis ing neuroprotective approaches, and a clinical perspective on the challenges involved in establishing the efficacy of these approaches through appropriate clinical trials. Section I, 'Mechanistic Approaches to CNS Neuroprotection,' reviews major injury mechanisms that have formed the basis for many past and present clinical trials conducted around the world. Dr. KIM and colleagues, Washington University School of Medicine, review the status of blocking excitotoxicity as an approach to CNS neuroprotection. Dr. WANG, Pfizer Global Research and Development,Ann Arbor Laboratories, outlines evidence supporting a contri bution of apoptosis to pathological neuronal or glial cell loss. Drs. BECKER and HALLENBECK, University of Washington and the National Institute on Neuro logical Diseases and Stroke, respectively, argue that inhibiting inflammatory pathways in the brain can be neuroprotective. Dr.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 528 pp. Englisch.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - 'CNS neuroprotection' was a common subject of papers, symposia, and reviews during the previous 'decade of the brain. ' Indeed, in recent years, experimental study of putative neuroprotective agents prompted clinical trials of numerous drug candidates in acute and chronic human neurodegenerative conditions. While the outcomes of these trials have not been as successful as initially hoped, these were early explorations, and the pipeline of relevant ideas continues to grow in strength and depth. We predict that early in this new millennium, crippling disorders such as stroke and Alzheimer's disease will be treated effectively by therapeutic neuroprotective strategies. This volume of the Handbook of Experimental Pharmacology titled eNS Neuroprotection provides a pharmacological perspective on currently promis ing neuroprotective approaches, and a clinical perspective on the challenges involved in establishing the efficacy of these approaches through appropriate clinical trials. Section I, 'Mechanistic Approaches to CNS Neuroprotection,' reviews major injury mechanisms that have formed the basis for many past and present clinical trials conducted around the world. Dr. KIM and colleagues, Washington University School of Medicine, review the status of blocking excitotoxicity as an approach to CNS neuroprotection. Dr. WANG, Pfizer Global Research and Development,Ann Arbor Laboratories, outlines evidence supporting a contri bution of apoptosis to pathological neuronal or glial cell loss. Drs. BECKER and HALLENBECK, University of Washington and the National Institute on Neuro logical Diseases and Stroke, respectively, argue that inhibiting inflammatory pathways in the brain can be neuroprotective. Dr.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - 'CNS neuroprotection' was a common subject of papers, symposia, and reviews during the previous 'decade of the brain. ' Indeed, in recent years, experimental study of putative neuroprotective agents prompted clinical trials of numerous drug candidates in acute and chronic human neurodegenerative conditions. While the outcomes of these trials have not been as successful as initially hoped, these were early explorations, and the pipeline of relevant ideas continues to grow in strength and depth. We predict that early in this new millennium, crippling disorders such as stroke and Alzheimer's disease will be treated effectively by therapeutic neuroprotective strategies. This volume of the Handbook of Experimental Pharmacology titled eNS Neuroprotection provides a pharmacological perspective on currently promis ing neuroprotective approaches, and a clinical perspective on the challenges involved in establishing the efficacy of these approaches through appropriate clinical trials. Section I, 'Mechanistic Approaches to CNS Neuroprotection,' reviews major injury mechanisms that have formed the basis for many past and present clinical trials conducted around the world. Dr. KIM and colleagues, Washington University School of Medicine, review the status of blocking excitotoxicity as an approach to CNS neuroprotection. Dr. WANG, Pfizer Global Research and Development,Ann Arbor Laboratories, outlines evidence supporting a contri bution of apoptosis to pathological neuronal or glial cell loss. Drs. BECKER and HALLENBECK, University of Washington and the National Institute on Neuro logical Diseases and Stroke, respectively, argue that inhibiting inflammatory pathways in the brain can be neuroprotective. Dr.

Hardcover. Zustand: Brand New. 500 pages. 9.75x6.50x1.00 inches. In Stock.